CD40 and pulmonary fibrosis: Overexpression of CXXC5 inhibited the progression of bleomycin-induced pulmonary fibrosis in mice by inhibiting the CD40/CD40L signaling pathway, which is possibly a new target for the treatment of pulmonary fibrosis.